“…Several GWAS for AITD (HT or GD), hypothyroidism, positivity for anti-thyroid (anti-TPO or anti-Tg) antibodies, and thyroid function parameters (including TSH or fT 4 levels), have been undertaken ( Table 2 ) ( 133 – 135 , 139 – 146 , 148 , 154 , 155 , 157 – 160 ). Some GWAS-identified AITD susceptibility loci have been replicated in different populations ( Table 2 ) ( 136 – 138 , 147 , 149 – 153 , 156 ); however, HT is rather poorly represented among GWAS. Numerous studies have been performed using small cohorts or patients with HT and GD grouped together ( 128 , 161 ).…”